eli lilly oral glp 1 Lilly's New GLP-1 Orforglipron Beats Semaglutide In Diabetes Trials; FDA Filing Near Eli Lilly's oral GLP-1 pill

They come from the medications effect on the gut and brain, not from where you injected

Jungnik A, Arrubla Martinez J, Plum-Morschel L, Kapitza C, Lamers D, Thamer C, et al

The basket design reflects the recognition that obesity does not exist in isolation: its comorbidities are the clinical problem, and a drug that can address body weight, liver fat, glycaemic control, and joint load simultaneously changes the calculus

Many patients find headaches improve over the first few months of stable GLP-1 therapy

The side effects are usually milder than what you experienced with the very first dose and resolve more quickly, typically within a few days to a week